Inhibition of lung cancer cells A549 and H460 by curcuminoid extracts and nanoemulsions prepared from Curcuma longa Linnaeus

International Journal of Nanomedicine

Volumn 10, Issue , 2015, Pages 5059-5080

  Chang, Hong Bin ^a   Chen, Bing Huei ^a  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Apoptosis mechanism; Cell cycle; Curcuma longa linnaeus; Curcuminoid extract; Curcuminoid nanoemulsion; Lung cancer cell

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CDK1 PROTEIN; CURCUMA LONGA EXTRACT; CURCUMIN; CYCLIN B; CYTOCHROME C; DEMETHOXYCURCUMIN; DIDEMETHOXYCURCUMIN; POLYSORBATE 80; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG; WATER; BIS(4-HYDROXYCINNAMOYL)METHANE; CASP3 PROTEIN, HUMAN; CASP8 PROTEIN, HUMAN; CASP9 PROTEIN, HUMAN; CCNB1 PROTEIN, HUMAN; CDK1 PROTEIN, HUMAN; CYCLIN B1; CYCLIN DEPENDENT KINASE; EMULSION; NANOMATERIAL; PLANT EXTRACT;

A549 CELL LINE; APOPTOSIS; ARTICLE; BIOCHEMICAL COMPOSITION; CANCER INHIBITION; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DETERMINATION; ENZYME ACTIVITY; EPITHELIUM CELL; G2 PHASE CELL CYCLE CHECKPOINT; H460 CELL LINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LUNG CANCER CELL LINE; MOLECULAR STABILITY; NANOEMULSION; PARTICLE SIZE; PROTEIN EXPRESSION; ANALOGS AND DERIVATIVES; CELL CYCLE; CHEMISTRY; CURCUMA; DOSE RESPONSE; DRUG EFFECTS; EMULSION; GENETICS; LUNG TUMOR; METABOLISM; MITOCHONDRION; PATHOLOGY; TUMOR CELL LINE;

CURCUMA LONGA;

APOPTOSIS; CASPASE 3; CASPASE 8; CASPASE 9; CELL CYCLE; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CURCUMA; CURCUMIN; CYCLIN B1; CYCLIN-DEPENDENT KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; EMULSIONS; HUMANS; LUNG NEOPLASMS; MITOCHONDRIA; NANOSTRUCTURES; PLANT EXTRACTS;

EID: 84939610609     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S87225     Document Type: Article

References (57)

1. Tsai YM, Jan WC, Chien CF, Lee WC, Lin LC, Tsai TH. Optimized nano-formulation on the bioavailability of hydrophobic polyphenol, curcumin, in freely-moving rats. Food Chem. 2011;127(3):918-925.
2. Bar-Sela G, Schaffer M. An evidence-based perspective of Curcuma longa (Turmeric) for cancer patients. In: Cho WCS, editor. Evidence-based Anticancer Materia Medica. the Netherlands: Springer; 2011:225-243.
3. Henry BS. Natural food colours. In: Houghton JD and Hendry GAF, editors. Natural Food Colorants. New York, USA: Springer; 1996:40-79.
4. Anand P, Kunnumakkara AB, Newman R, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4(6): 807-818.
5. Ministry of Health. Statistics of Cause of Death. Taipei, Taiwan: Ministry of Health; 2014.
6. Taiwan Lung Cancer Society. Hundreds of Questions for Lung Cancer. Taipei, Taiwan: Taiwan Lung Cancer Society; 2014.
7. Herbst RS, Heymach JV, Lippman SM. Lung cancer. N Engl J Med. 2008;359(13):1367-1380.
8. American Cancer Society. Lung Cancer (Non-Small Cell). American Joint Committee on Cancer Staging (AJCC-2010). Atlanta, Georgia; 2013.
9. Kim DS, Park SY, Kim JK. Curcuminoids from Curcuma longa L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from betaA(1-42) insult. Neurosci Lett. 2001;303(1):57-61.
10. Shishodia S, Amin HM, Lai R, Aggarwal BB. Curcumin (diferuloylmethane) inhibits constitutive NF-KappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol. 2005;70:700-713.
11. Lin SS, Lai KC, Hsu SC, et al. Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and-9 and vascular endothelial growth factor (VEGF). Cancer Lett. 2009;285(2):127-133.
12. Aggarwal BB, Banerjee S, Bharadwaj U, Sung B, Shishodia S, Sethi G. Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines. Biochem Pharmacol. 2007;73(7):1024-1032.
13. Tharakan ST, Inamoto T, Sung B, Aggarwal BB, Kamat AM. Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers. Biochem Pharmacol. 2010;79(2):218-228.
14. Kang HJ, Lee SH, Price JE, Kim LS. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB in breast cancer cells and potentiates the growth inhibitory effect of paclitaxel in a breast cancer nude mice model. Breast J. 2009;15(3):223-229.
15. Chen YJ, Inbaraj BS, Pu YS, Chen BH. Development of lycopene micelle and lycopene chylomicron and a comparison of bioavailability. Nanotechnology. 2014;25(15):155102.
16. Huang RFS, Wei YJ, Inbaraj BS, Chen BH. Inhibition of colon cancer cell growth by nanoemulsion carrying gold nanoparticles and lycopene. Int J Nanomedicine. 2015;10:2823-2846.
17. Li R, Xiang C, Ye M, Li HF, Zhang X, Guo DA. Qualitative and quantitative analysis of curcuminoids in herbal medicines derived from Curcuma species. Food Chem. 2011;126(4):1890-1895.
18. Bisht S, Feldmann G, Soni S, et al. Polymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): a novel strategy for human cancer therapy. J Nanobiotechnology. 2007;5:3.
19. Statistical Analysis System. SAS Procedures and SAS/Graph User’s Guide. Version 6. Cary, NC: SAS Institute Inc. 2014.
20. Barrero MM, Carrero RJ. Pigments evaluation in turmeric cropped in Venezuela. Agron Trop. 1999;49:491-504.
21. Chempakam B, Leela NK, John SP. Distribution of curcuminoids during rhizome development in turmeric (Curcuma longa L.). Spices Aromat Plants. 2000;15:293-296.
22. Jiang H, Timmermann BN, Gang DR. Use of liquid chromatography-electrospray ionization tandem mass spectrometry to identify diarylheptanoids in turmeric (Curcuma longa L.) rhizome. J Chromatogr A. 2006;1111:21-31.
23. Inoue K, Hamasaki S, Yoshimura Y, et al. Validation of LC/ Electrospray-MS for determination of major curcuminoids in foods. J Liq Chrom Rel Techniq. 2003;26:53-62.
24. Karioti A, Fani E, Vincieri FF, Bilia AR. Analysis and stability of the constituents of Curcuma longa and Harpagophytum procumbens tinctures by HPLC-DAD and HPLC-ESI-MS. J Pharm Biomed Anal. 2011;55(3):479-489.
25. Tonnesen HH. Solubility, chemical and photochemical stability of curcumin in surfactant solutions. Studies of curcumin and curcuminoids, XXVIII. Pharmazie. 2002;57(12):820-824.
26. Goel A, Jhurani S, Aggarwal BB. Multi-targeted therapy by curcumin: how spicy is it? Mol Nutr Food Res. 2008;52(9):1010-1030.
27. Lao CD, Ruffin MT, Normolle D, et al. Dose escalation of a curcuminoid formulation. BMC Complement Altern Med. 2006;6:10.
28. Huang Q, Yu H, Ru Q. Bioavailability and delivery of nutraceuticals using nanotechnology. J Food Sci. 2010;75(1):R50-R57.
29. Bansal SS, Goel M, Aquil F, Vadhanam MV, Gupta RC. Advanced drug delivery systems of curcumin for cancer chemoprevention. Cancer Prev Res (Phila). 2011;4(8):1158-1171.
30. Wang X, Jiang Y, Wang YW, Huang MT, Ho CT, Huang Q. Enhancing anti-inflammation activity of curcumin through O/W nanoemulsions. Food Chem. 2008;108(2):419-424.
31. Onoue S, Takahashi H, Kawabata Y, et al. Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability. J Pharm Sci. 2010;99(4): 1871-1881.
32. Lin YL, Liu YK, Tsai NM, et al. A lipo-PEG-PEI complex for encapsulating curcumin that enhances its antitumor effects on curcumin-sensitive and curcumin-resistance cells. Nanomedicine. 2012;8(3):318-327.
33. Yoon H, Lee CY. Effect of selected phytochemicals on cell proliferation in A549 lung cancer cells. Food Sci Biotechnol. 2010;19: 1063-1068.
34. Zhang J, Zhang T, Ti X, et al. Curcumin promotes apoptosis in A549/DDP multidrug-resistant human lung adenocarcinoma cells through an miRNA signaling pathway. Biochem Biophys Res Comm. 2010;399:1-6.
35. Wu SH, Hang LW, Yang JS, et al. Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through ER stress and caspase cascade-and mitochondrial-dependent pathways. Anticancer Res. 2010;30(6):2125-2133.
36. Mukerjee A, Vishwanatha JK. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Res. 2009;29(10):3867-3875.
37. Mohanty C, Sahoo SK. The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. Biomaterials. 2010;31(25):6597-6611.
38. Anuchapreeda S, Fukumori Y, Okonogi S, Ichikawa H. Preparation of lipid nanoemulsion incorporating curcumin for cancer therapy. J Nanotechnol. 2012;2012:1-11.
39. Lin SS, Huang HP, Yang JS, et al. DNA damage and endoplasmic reticulum stress mediated curcumin-induced cell cycle arrest and apoptosis in human lung carcinoma A-549 cells through the activation caspases cascade-and mitochondrial-dependent pathway. Cancer Lett. 2008;272:77-90.
40. Su CC, Wang MJ, Chiu TL. The anti-cancer efficacy of curcumin scrutinized through core signaling pathways in glioblastoma. Int J Mol Med. 2010;26(2):217-224.
41. Cheng CY, Lin YH, Su CC. Curcumin inhibits the proliferation of human hepatocellular carcinoma J5 cells by inducing endoplasmic reticulum stress and mitochondrial dysfunction. Int J Mol Med. 2010;26(5):673-678.
42. Van Erk MJ, Teuling E, Staal YC, et al. Time-and dose-dependent effect of curcumin on gene expression in human colon cancer cells. J Carcinog. 2004;3(1):8.
43. Li HQ, Jin LJ, Wu FF, et al. Effect of curcumin on proliferation, cell cycle, and caspases and MCF-7 cells. Afr J Pharm Pharmacol. 2012; 6(12):864-870.
44. Chen QY, Shi JG, Yao QH, et al. Lysosomal membrane permeabilization is involved in curcumin-induced apoptosis of A549 lung carcinoma cells. Mol Cell Biochem. 2012;359(1-2):389-398.
45. Chen Q, Wang Y, Xu K, et al. Curcumin induces apoptosis in human lung adenocarcinoma A549 cells through a reactive oxygen species-dependent mitochondrial signaling pathway. Oncol Rep. 2010;23:397-403.
46. Wu Q, Hou YL, Sun B, Zhuang K, Zhang HC, Jin DJ. Curcumin induce apoptosis of CNE-2z cells via caspase-dependent mitochondrial intrinsic pathway. Afr J Pharm Pharmacol. 2011;7(5):1748-1756.
47. Yu J, Zhou XM, He XS, Dai MH, Zhang Q. Curcumin induces apoptosis involving bax/bcl-2 in human hepatoma SMMC-7721 cells. Asian Pac J Cancer Prev. 2011;12:1925-1929.
48. Daniel NN, Korsmeyer SJ. Cell death: critical control points. Cell. 2004;116(2):205-219.
49. Vousden KH, Lane DP. p53 in health and disease. Nat Rev Mol Cell Biol. 2007;8(4):275-283.
50. Shu KX, Li B, Wu LX. The p53 network: p53 and its downstream genes. Colloids Surf B Biointerfaces. 2007;55(1):10-18.
51. Lin YL, Su YT, Chen BH. A study on inhibition mechanism of breast cancer cells by bis-type triaziquone. Eur J Pharmacol. 2010;637(1-3):1-10.
52. Yang CL, Liu YY, Ma YG, et al. Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway. PLoS One. 2012;7(5):e37960.
53. Kuo CL, Wu SY, Ip SW, et al. Apoptotic death in curcumin-treated NPC-TW 076 human nasopharyngeal carcinoma cells is mediated through the ROS, mitochondrial depolarization and caspase-3-dependent signaling responses. Int J Oncol. 2011;39(2):319-328.
54. Ip SW, Wu SY, Yu CC, et al. Induction of apoptotic death by curcumin in human tongue squamous cell carcinoma SCC-4 cells is mediated through endoplasmic reticulum stress and mitochondria-dependent pathways. Cell Biochem Funct. 2011;29(8):641-650.
55. O’Sullivan-Coyne G, O’Sullivan GC, O’Donovan TR, Piwocka K, McKenna SL. Curcumin induces apoptosis-independent death in oesophageal cancer cells. British J Cancer. 2009;101(9):1585-1595.
56. Weir NM, Selvendiran K, Kutala VK, et al. Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK. Cancer Biol Ther. 2007;6(2):178-184.
57. Woo JH, Kim YH, Choi YJ, et al. Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. Carcinogenesis. 2003;24(7):1199-1208.